| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 07/29/2004 | CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/28/2004 | EP1440064A1 Process for the preparation of (pyrimmidin-2-yl)methyl ketones |
| 07/28/2004 | EP1440063A1 Process for the preparation of 1-(pyrimidin-2-yl)propan-2-ones |
| 07/28/2004 | EP0979064B1 Oxidation colorants |
| 07/28/2004 | CN1516690A Heterocyclic derivatives and medicines |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1515673A Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative |
| 07/28/2004 | CN1159312C Novel poyrimidine derivatives and process for preparation thereof |
| 07/28/2004 | CN1159311C Dihydropyrimidines |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767909 Cardiovascular disorders; vasoconstriction |
| 07/27/2004 | CA2243591C Halogen pyrimidines and its use thereof as parasite abatement means |
| 07/27/2004 | CA2118512C Agents for treating substance abuse disorders |
| 07/22/2004 | WO2004061084A2 Modulation of protein functionalities |
| 07/22/2004 | WO2004060883A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors |
| 07/22/2004 | WO2004060376A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004060306A2 Anti-inflammatory medicaments |
| 07/22/2004 | WO2004060305A2 Anti-cancer medicaments |
| 07/22/2004 | WO2004029045A3 Process for preparing quinazoline rho-kinase inhibitors and intermediates thereof |
| 07/22/2004 | WO2004014384A3 Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | WO2002096886A8 Pyrimidine derivatives |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142984 Applying to plants |
| 07/22/2004 | US20040142981 Sterilization, antiseptics for bacteria infections |
| 07/22/2004 | US20040142975 Antiarthritic agents; canticancer agents; antitumor agents; cardiovascular diosrders; skin diosrders; vision defects; antiinflammatory agents |
| 07/22/2004 | US20040142954 Antiinflammatory agents; antihistamines; Alzheimer's disease; anticholesterol agents; cardiovascular disorders; inflammatory bowel disorders; antitumor agents; antidiabetic agents; brain disorders; multiple sclerosis |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142951 3H-quinazolin-4-one derivatives as MAO-B inhibitors |
| 07/22/2004 | US20040142950 Amide and ester matrix metalloproteinase inhibitors |
| 07/22/2004 | US20040142949 Compounds, compositions, and methods |
| 07/22/2004 | US20040142930 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects |
| 07/22/2004 | US20040142451 one linker, a biomolecule coupled to the linker, and cyclohexane derivatives |
| 07/22/2004 | CA2513627A1 Anti-inflammatory medicaments |
| 07/22/2004 | CA2512183A1 Pyrimidine-4,6-dicarboxylic acid diamides for use as selective mmp 13 inhibitors |
| 07/22/2004 | CA2511873A1 Modulation of protein functionalities |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | CA2510050A1 The r-isomer of beta amino acid compounds as integrin receptor antagonists derivatives |
| 07/21/2004 | EP1439187A1 O2-Arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 07/21/2004 | EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/21/2004 | EP1439176A1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 07/21/2004 | EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/21/2004 | EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 07/21/2004 | EP1100786B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof |
| 07/21/2004 | EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers |
| 07/21/2004 | CN1513844A New Carboxglic acid derivative, its preparation and application |
| 07/21/2004 | CN1513843A Cyano substituted heterocyclic ketene semiamine contained molecular material and its preparation method |
| 07/21/2004 | CN1158266C Compounds |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 07/20/2004 | US6765096 Antiallergic agent, immunosuppressant |
| 07/20/2004 | US6765089 Protecting and linking groups for organic synthesis on solid supports |
| 07/20/2004 | US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/20/2004 | US6765006 Antagonists of amino-3-hydroxy-5-methylisoxazole-4-propionic acid (ampa) ionotropic receptors; neurodegenerative, alzheimer's, and huntington's disease; amyotrophic lateral sclerosis; schizophrenia, excitatory amino acid deficiency |
| 07/20/2004 | US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/15/2004 | WO2004058787A2 Fluorogenic enzyme substrates and methods of preparation |
| 07/15/2004 | WO2004058757A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 07/15/2004 | WO2004058756A1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors |
| 07/15/2004 | WO2004058723A1 Biphenyl derivatives and their use as fungicides |
| 07/15/2004 | WO2004058713A1 Differential tumor cytotoxocity compounds and compositions |
| 07/15/2004 | WO2004058704A2 Quinazolinones as potassium channel modulators |
| 07/15/2004 | WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/15/2004 | WO2004058676A1 Perfluoroallyloxy compound and liquid-crystal composition containing the compound |
| 07/15/2004 | WO2004058174A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 07/15/2004 | WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
| 07/15/2004 | WO2004034967A3 2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety |
| 07/15/2004 | WO2004006846A3 Receptor-type kinase modulators and methods of use |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138243 Antiinflammatory agents; asthma; Alzheimer's disease; Aids; antidiabetic agents; inflmamtory bowel disorders; anticholesterol agents; antitumor agenst |
| 07/15/2004 | US20040138242 Dihydropyrimidines and uses thereof |
| 07/15/2004 | US20040138241 Urogenital disorders; benign protatic hyperplasia |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | DE10300017A1 Selektive MMP 13 Inhibitoren Selective MMP inhibitors 13 |
| 07/15/2004 | CA2506897A1 Fluorogenic enzyme substrates and methods of preparation |
| 07/14/2004 | EP1437348A1 6-methyl-2,4-diamino-pyrimidine derivatives, process for preparation, compositions containing them and their uses as basic neutralising agents |
| 07/14/2004 | EP1436287A2 Small organic molecule regulators of cell proliferation |
| 07/14/2004 | EP1436267A1 Lactam derivatives as antagonists for human 11cby receptors |
| 07/14/2004 | EP1435963A2 Reduced toxicity cisplatin formulations and methods for using the same |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435782A1 Treatment for cystic fibrosis |
| 07/14/2004 | EP1282595B1 Novel phenyl-propargylether derivatives |
| 07/14/2004 | EP1254120B1 Use of pyrimidine endothelin antagonists in companion animals |
| 07/14/2004 | CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer |
| 07/14/2004 | CN1512988A Pyrimidine, Triazine and pyrazine derivatives as glutamate receptors |
| 07/14/2004 | CN1512986A Substituted anilide derivatives, intermediates thereof, agricultural and horticultural chemicals and their usage |